Grouping of variations: questions and answers
Submitted by Anonymous (not verified) on 13 November 2023 - 14:14
Grouping of variations: questions and answers
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 13 November 2023 - 14:13
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Multilateral coalitions and initiatives
Submitted by Anonymous (not verified) on 13 November 2023 - 13:57
Multilateral coalitions and initiatives
Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo,doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: , therapeutic area: , PIP number: P/0504/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:38
Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo,doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: , therapeutic area: , PIP number: P/0504/2022
Opinion/decision on a Paediatric investigation plan (PIP): Pifeltro,doravirine, decision type: , therapeutic area: , PIP number: P/0505/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:33
Opinion/decision on a Paediatric investigation plan (PIP): Pifeltro,doravirine, decision type: , therapeutic area: , PIP number: P/0505/2022
Opinion/decision on a Paediatric investigation plan (PIP): Braftovi,Encorafenib, decision type: , therapeutic area: , PIP number: P/0487/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:29
Opinion/decision on a Paediatric investigation plan (PIP): Braftovi,Encorafenib, decision type: , therapeutic area: , PIP number: P/0487/2022
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent,dupilumab, decision type: , therapeutic area: , PIP number: P/0541/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:23
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent,dupilumab, decision type: , therapeutic area: , PIP number: P/0541/2022
Opinion/decision on a Paediatric investigation plan (PIP): binimetinib, decision type: , therapeutic area: , PIP number: P/0488/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:18
Opinion/decision on a Paediatric investigation plan (PIP): binimetinib, decision type: , therapeutic area: , PIP number: P/0488/2022
Opinion/decision on a Paediatric investigation plan (PIP): Tecovirimat (monohydrate), decision type: , therapeutic area: , PIP number: P/0540/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:14
Opinion/decision on a Paediatric investigation plan (PIP): Tecovirimat (monohydrate), decision type: , therapeutic area: , PIP number: P/0540/2022
Ethical use of animals in medicine testing
Submitted by Anonymous (not verified) on 13 November 2023 - 13:14
Ethical use of animals in medicine testing